Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Jolanta Krajewska, Tomasz Gawlik & Barbara Jarzab. (2017) Advances in small molecule therapy for treating metastatic thyroid cancer. Expert Opinion on Pharmacotherapy 18:11, pages 1049-1060.
Read now
Read now
Jolanta Krajewska, Tomasz Olczyk & Barbara Jarzab. (2016) Cabozantinib for the treatment of progressive metastatic medullary thyroid cancer. Expert Review of Clinical Pharmacology 9:1, pages 69-79.
Read now
Read now
Pietro Santulli, Louis Marcellin, Claudia Tosti, Sandrine Chouzenoux, Olivier Cerles, Bruno Borghese, Frédéric Batteux & Charles Chapron. (2015) MAP kinases and the inflammatory signaling cascade as targets for the treatment of endometriosis?. Expert Opinion on Therapeutic Targets 19:11, pages 1465-1483.
Read now
Read now
Articles from other publishers (23)
Qian Zhong, Xina Xiao, Yijie Qiu, Zhiqiang Xu, Chunyu Chen, Baochen Chong, Xinjun Zhao, Shan Hai, Shuangqing Li, Zhenmei An & Lunzhi Dai. (2023) Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications. MedComm 4:3.
Crossref
Crossref
Saied Mirshahidi, Isabella J. Yuan, Alfred Simental, Steve C. Lee, Nathaniel R. Peterson, Pedro A. Andrade Filho, Thomas Murry, Penelope Duerksen-Hughes & Xiangpeng Yuan. (2023) Targeting Tumor Microenvironment Akt Signaling Represents a Potential Therapeutic Strategy for Aggressive Thyroid Cancer. International Journal of Molecular Sciences 24:6, pages 5471.
Crossref
Crossref
Cole D Davidson, Jennifer A Tomczak, Eyal Amiel & Frances E Carr. (2022) Inhibition of Glycogen Metabolism Induces Reactive Oxygen Species-Dependent Cytotoxicity in Anaplastic Thyroid Cancer in Female Mice. Endocrinology 163:12.
Crossref
Crossref
Ayesha Munir & Irina G. Veytsman. 2022. A Case-Based Guide to Clinical Endocrinology. A Case-Based Guide to Clinical Endocrinology
129
140
.
Sze Wan Hung, Ruizhe Zhang, Zhouyurong Tan, Jacqueline Pui Wah Chung, Tao Zhang & Chi Chiu Wang. (2021) Pharmaceuticals targeting signaling pathways of endometriosis as potential new medical treatment: A review. Medicinal Research Reviews 41:4, pages 2489-2564.
Crossref
Crossref
Caitlin O. Caperton, Lee Ann Jolly, Nicole Massoll, Andrew J. Bauer & Aime T. Franco. (2021) Development of Novel Follicular Thyroid Cancer Models Which Progress to Poorly Differentiated and Anaplastic Thyroid Cancer. Cancers 13:5, pages 1094.
Crossref
Crossref
Iago Dillion Lima Cavalcanti & José Cleberson Santos SoaresIago Dillion Lima Cavalcanti & José Cleberson Santos Soares. 2021. Advances in Cancer Treatment. Advances in Cancer Treatment
57
78
.
Nigel Fleeman, Rachel Houten, Adrian Bagust, Marty Richardson, Sophie Beale, Angela Boland, Yenal Dundar, Janette Greenhalgh, Juliet Hounsome, Rui Duarte & Aditya Shenoy. (2020) Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation. Health Technology Assessment 24:2, pages 1-180.
Crossref
Crossref
Ilaria Peluso, Nagendra Sastry Yarla, Roberto Ambra, Gianni Pastore & George Perry. (2019) MAPK signalling pathway in cancers: Olive products as cancer preventive and therapeutic agents. Seminars in Cancer Biology 56, pages 185-195.
Crossref
Crossref
Behrouz Salehian, Simon Y Liem, Hoda Mojazi Amiri & Ellie Maghami. (2019) Clinical Trials in Management of Anaplastic Thyroid Carcinoma; Progressions and Set Backs: A Systematic Review. International Journal of Endocrinology and Metabolism In Press:In Press.
Crossref
Crossref
Yinlong Zhao, Lili Zhong & Heqing Yi. (2019) A review on the mechanism of iodide metabolic dysfunction in differentiated thyroid cancer. Molecular and Cellular Endocrinology 479, pages 71-77.
Crossref
Crossref
Andrey P. Polyakov, Alexander V. Mordovskiy, Petr A. Nikiforovich, Mikhail V. Ratushnyy, Irina V. Rebrikova, Anna V. Boyko, Larisa V. Bolotina & Artem R. Gevorcov. (2018) CLINICAL CASES OF THE EFFICACY OF THERAPY MULTIKINASE INHIBITORS OF METASTATIC RADIOID-REFRACTORY DIFFERENTIATED THYROID CANCER. Endocrine Surgery 12:2, pages 81-88.
Crossref
Crossref
Tirtha K. Das, Jessica Esernio & Ross L. Cagan. (2018) Restraining Network Response to Targeted Cancer Therapies Improves Efficacy and Reduces Cellular Resistance. Cancer Research 78:15, pages 4344-4359.
Crossref
Crossref
Mari Kogiso, Lin Qi, Holly Lindsay, Yulun Huang, Xiumei Zhao, Zhigang Liu, Frank K. Braun, Yuchen Du, Huiyuan Zhang, Goeun Bae, Sibo Zhao, Sarah G. Injac, Mary Sobieski, David Brunell, Vidya Mehta, Diep Tran, Jeffrey Murray, Patricia A. Baxter, Xiao-Jun Yuan, Jack M. Su, Adekunle Adesina, Laszlo Perlaky, Murali Chintagumpala, D. Williams Parsons, Ching C. Lau, Clifford C. Stephan, Xinyan Lu & Xiao-Nan Li. (2017)
Xenotransplantation of pediatric low grade gliomas confirms the enrichment of
BRAF
V600E mutation and preservation of
CDKN2A
deletion in a novel orthotopic xenograft mouse model of progressive pleomorphic xanthoastrocytoma
. Oncotarget 8:50, pages 87455-87471.
Crossref
Crossref
Susanne Singer, Susan Jordan, Laura D Locati, Monica Pinto, Iwona M Tomaszewska, Cláudia Araújo, Eva Hammerlid, E Vidhubala, Olga Husson, Naomi Kiyota, Christine Brannan, Dina Salem, Eva M Gamper, Juan Ignacio Arraras, Georgios Ioannidis, Guy Andry, Johanna Inhestern, Vincent Grégoire, Lisa Licitra & _ _. (2017) The EORTC module for quality of life in patients with thyroid cancer: phase III. Endocrine-Related Cancer 24:4, pages 197-207.
Crossref
Crossref
Outi Uimari, Nilufer Rahmioglu, Dale R. Nyholt, Katy Vincent, Stacey A. Missmer, Christian Becker, Andrew P. Morris, Grant W. Montgomery & Krina T. Zondervan. (2017) Genome-wide genetic analyses highlight mitogen-activated protein kinase (MAPK) signaling in the pathogenesis of endometriosis. Human Reproduction 32:4, pages 780-793.
Crossref
Crossref
Dwight Owen & Manisha H. Shah. 2017. Management of Thyroid Nodules and Differentiated Thyroid Cancer. Management of Thyroid Nodules and Differentiated Thyroid Cancer
433
450
.
Shuangge Liu, Xiaoyan Xin, Teng Hua, Rui Shi, Shuqi Chi, Zhishan Jin & Hongbo Wang. (2016) Efficacy of Anti-VEGF/VEGFR Agents on Animal Models of Endometriosis: A Systematic Review and Meta-Analysis. PLOS ONE 11:11, pages e0166658.
Crossref
Crossref
Susanne SingerOlga HussonIwona M. TomaszewskaLaura D. LocatiNaomi KiyotaUlrike Scheidemann-WespDirk HofmeisterMelanie WinterbothamChristine BrannanCláudia AraújoEva M. GamperDagmara KulisHarald RimmeleGuy AndryLisa Licitra. (2016) Quality-of-Life Priorities in Patients with Thyroid Cancer: A Multinational European Organisation for Research and Treatment of Cancer Phase I Study. Thyroid 26:11, pages 1605-1613.
Crossref
Crossref
Lee Ann Jolly, Sergey Novitskiy, Phillip Owens, Nicole Massoll, Nikki Cheng, Wei Fang, Harold L. Moses & Aime T. Franco. (2016) Fibroblast-Mediated Collagen Remodeling Within the Tumor Microenvironment Facilitates Progression of Thyroid Cancers Driven by BrafV600E and Pten Loss. Cancer Research 76:7, pages 1804-1813.
Crossref
Crossref
Brett D. McKinnon, Vida Kocbek, Kostantinos Nirgianakis, Nick A. Bersinger & Michael D. Mueller. (2016) Kinase signalling pathways in endometriosis: potential targets for non-hormonal therapeutics. Human Reproduction Update 22:3, pages 382-403.
Crossref
Crossref
Eleonora Farina, Fabio Monari, Giovanni Tallini, Andrea Repaci, Renzo Mazzarotto, Francesca Giunchi, Riccardo Panzacchi, Silvia Cammelli, Gilbert D. A. Padula, Francesco Deodato, Renato Pasquali, Stefano Fanti, Michelangelo Fiorentino & Alessio G. Morganti. (2015) Unusual Thyroid Carcinoma Metastases: a Case Series and Literature Review. Endocrine Pathology 27:1, pages 55-64.
Crossref
Crossref
Mahaut Leconte, Pietro Santulli, Sandrine Chouzenoux, Louis Marcellin, Olivier Cerles, Charles Chapron, Bertrand Dousset & Frédéric Batteux. (2015) Inhibition of MAPK and VEGFR by Sorafenib Controls the Progression of Endometriosis. Reproductive Sciences 22:9, pages 1171-1180.
Crossref
Crossref